论文部分内容阅读
读本刊1962年11期所载《气管滴入抗痨药物治疗肺结核空洞问题的探讨》一文后,对执笔者重点探讨的二个问题:(一)气管滴入抗痨药物治疗肺结核空洞的临床疗效;(二)如何提高其治疗效果;有很大收获。但感到其中有些问题的探讨似嫌不足,而在另一些问题上个人有不同看法,故愿提出与郝(?)医师商榷。一、第一部分临床疗效中,综合的资料不够统一:临床疗效,855例空洞,总的闭合率为63.6%。但在分析疗效与空洞性质、大小、洞龄、部位,胸膜粘连,过去用药和治疗时间的关系时。所综合的病例数分别为588例、
Read the magazine published in 1962 11, “tracheal instillation of anti-tuberculosis drug treatment of tuberculosis hole” article, the author focused on two issues: (a) tracheal instillation of anti-tuberculosis drug treatment of tuberculosis in the clinical Efficacy; (B) how to improve its therapeutic effect; a great harvest. However, I feel that some of these problems may not be explored enough. On the other hand, I personally have different views. Therefore, I would like to discuss with Dr. Hao. First, the first part of the clinical efficacy, the comprehensive data is not uniform enough: clinical efficacy, 855 cases of holes, the total closure rate was 63.6%. However, in analyzing the relationship between efficacy and the nature of the cavity, size, age, location, pleural adhesions, past medication and treatment time. The combined number of cases were 588 cases,